The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients
Public ClinicalTrials.gov record NCT00007436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-Label, Multicenter Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety of tenofovir disoproxil fumarate (tenofovir DF) in combination with other anti-HIV drugs in patients who have participated in other tenofovir DF studies (GS-98-902 or GS-99-907), are able to tolerate the drug at different doses, and may benefit from having tenofovir DF treatment.
Study identification
- NCT ID
- NCT00007436
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 0 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Bay AIDS Ctr | Berkeley | California | 94705 | — |
| Tower ID Med Associates | Los Angeles | California | 90048 | — |
| Pacific Horizons Med Group | San Francisco | California | 94115 | — |
| Harbor - UCLA Med Ctr | Torrance | California | 90502 | — |
| Univ of Colorado / Health Science Ctr | Denver | Colorado | 80262 | — |
| Physicans Home Service | Washington D.C. | District of Columbia | 20037 | — |
| Steinhart Medical Associates | Miami | Florida | 33133 | — |
| Dr Gerald Pierone Jr | Vero Beach | Florida | 32960 | — |
| Northstar Med Clinic | Chicago | Illinois | 60657 | — |
| CRI New England | Brookline | Massachusetts | 02146 | — |
| Univ of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Univ of Rochester Med Ctr | Rochester | New York | 14642 | — |
| Research & Education Group | Portland | Oregon | 97209 | — |
| Hershey Med Ctr | Hershey | Pennsylvania | 17033 | — |
| Anderson Clinical Research | Pittsburgh | Pennsylvania | 15221 | — |
| Roger Williams Med Ctr | Providence | Rhode Island | 02908 | — |
| Southwest Infectious Diseases Associates | Dallas | Texas | 75246 | — |
| Thomas Street Clinic | Houston | Texas | 77009 | — |
| Dr Philip C Craven | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00007436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00007436 live on ClinicalTrials.gov.